Physician

Joel Louis Gallagher, MD

According to 2025 Medicare claims, Joel Gallagher, MD (NPI: 1427349984) practices allergy/immunology in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is MOSES CONE AFFILIATED PHYSICIANS, INC. (NPI: 1861792004; TIN: 300554775) and primary practice location at 27401-1310. Gallagher is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Gallagher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 141 traditional Medicare patients, billed 8,472 HCPCS/CPT codes, and received $142,386 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,174 prescription claims across 398 beneficiaries totaling $2,021,361 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 152 claims. Open Payments data shows 169 records totaling $4,414. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $18,219 to $2,021,361. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,067 and ending at $2,509.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	71	1,323	$18,939
2018	128	4,868	$96,238
2019	165	6,009	$175,054
2020	137	5,897	$200,632
2021	186	9,182	$296,709
2022	196	8,563	$303,768
2023	149	7,043	$196,261
2024	141	8,472	$142,386

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	26	118	$18,219
2016	13	37	$3,155
2017	105	364	$93,161
2018	200	1,440	$489,884
2019	217	1,676	$734,203
2020	248	1,865	$863,042
2021	283	2,168	$948,546
2022	364	2,625	$1,530,326
2023	367	2,772	$1,721,279
2024	398	3,174	$2,021,361

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$34
2019	N/R	134	$122,079
2020	N/R	111	$117,045
2021	N/R	110	$125,178
2022	N/R	179	$153,063
2023	N/R	85	$98,953
2024	N/R	152	$158,236

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	30	30	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	75	115	$84
94010	Test to measure expiratory airflow and volume	36	55	$18
95165	Professional service for preparation and provision of 1 or more antigens	30	515	$10
95117	Professional service for multiple injections of allergen	42	469	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	120	3,304	$495,850
Xolair	Omalizumab	88	2,464	$335,598
Fasenra Pen	Benralizumab	36	1,960	$222,159
Fasenra	Benralizumab	34	1,792	$213,112
Glassia	Alpha-1-Proteinase Inhibitor	13	364	$164,775

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	17	$91,530
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	13	$62,954
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	15	$1,250
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	16	$876
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	17	$618

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	169	$4,414	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joel Louis Gallagher, MD?

Tedicare shows public-source Medicare data for Joel Louis Gallagher, MD (NPI 1427349984), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joel Louis Gallagher, MD have ACO affiliation data?

Joel Louis Gallagher, MD is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Joel Louis Gallagher, MD?

Joel Louis Gallagher, MD is linked to MOSES CONE AFFILIATED PHYSICIANS, INC. (billing NPI 1861792004) in the available physician profile data.

Does Joel Louis Gallagher, MD have Open Payments data?

Joel Louis Gallagher, MD has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.